Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 323-327

  Brown, J Martin ^a   Diehn, Maximilian ^a   Loo Jr , Billy W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Etanidazole; Hypoxic cell radiosensitizer; Stereotactic ablative radiotherapy (SABR); Stereotactic body radiation therapy (SBRT); Stereotactic radiosurgery (SRS)

Indexed keywords

ETANIDAZOLE; RADIOSENSITIZING AGENT;

ABLATION THERAPY; CANCER RADIOTHERAPY; CELL SURVIVAL; HYPOXIC CELL; LUNG TUMOR; NOTE; PRIORITY JOURNAL; RADIOTHERAPY; TUMOR VOLUME; CELL HYPOXIA; DRUG EFFECTS; HUMAN; LUNG NEOPLASMS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; RADIOSURGERY; STATISTICAL MODEL;

CELL HYPOXIA; CELL SURVIVAL; COMBINED MODALITY THERAPY; ETANIDAZOLE; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOSURGERY; TUMOR BURDEN;

EID: 77956529790     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.070     Document Type: Article

References (44)

1. J.M. Brown Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies Mol Med Today 6 2000 157 162
2. M. Hockel, and P. Vaupel Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects J Natl Cancer Inst 93 2001 266 276
3. R.F. Kallman The phenomenon of reoxygenation and its implications for fractionated radiotherapy Radiology 105 1972 135 142
4. R.F. Kallman, and M.J. Dorie Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response Int J Radiat Oncol Biol Phys 12 1986 681 685
5. J.M. Brown Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation Br J Radiol 52 1979 650 656
6. D.M. Brizel, S.P. Scully, and J.M. Harrelson Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 1996 941 943
7. M. Hockel, K. Schlenger, and B. Aral Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 1996 4509 4515
8. D.M. Brizel, R.K. Dodge, and R.W. Clough Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 1999 113 117
9. E.K. Rofstad, K. Sundfor, and H. Lyng Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis Br J Cancer 83 2000 354 359
10. B.G. Wouters, and J.M. Brown Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy Radiat Res 147 1997 541 550
11. Q.-T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
12. B.W. Loo, J. Shen, and S. Quinlan-Davidson Tumor size is a critical determinant of local control in single fraction stereotactic radiotherapy of pulmonary tumors Int J Radiat Oncol Biol Phys 72 2008 S467 S468
13. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
14. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
15. C. Park, L. Papiez, and S. Zhang Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
16. M. Kocher, R.P. Mueller, and M.U. Abacioglu Adjuvant whole brain radiotherapy vs. observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study Int J Radiat Oncol Biol Phys 75 2009 S5
17. J. Wulf, K. Baier, and G. Mueller Dose-response in stereotactic irradiation of lung tumors Radiother Oncol 77 2005 83 87
18. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
19. R.D. Timmerman, C. Park, and B.D. Kavanagh The North American experience with stereotactic body radiation therapy in non-small cell lung cancer J Thorac Oncol 2 2007 S101 S112
20. R. McCammon, T.E. Schefter, and L.E. Gaspar Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 2009 112 118
21. H. Hof, M. Muenter, and D. Oetzel Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC) Cancer 110 2007 148 155
22. P.W. Vaupel, and M. Hockel Oxygenation status of human tumors: A reappraisal using computerized pO2 histography P.W. Vaupel, D.K. Kelleher, M. Gunderoth, Tumor oxygenation 1995 Gustav Fischer Verlag Stuttgart 219 232
23. J.M. Brown The hypoxic cell: A target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture Cancer Res 59 1999 5863 5870
24. Q.-T. Le, E. Chen, and A. Salim An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers Clin Cancer Res 12 2006 1507 1514
25. K.A. Goodman, P.K. Sneed, and M.W. McDermott Relationship between pattern of enhancement and local control of brain metastases after radiosurgery Int J Radiat Oncol Biol Phys 50 2001 139 146
26. D.T. Chang, D. Schellenberg, and J. Shen Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 2009 665 672
27. Y. Yamada, M.H. Bilsky, and D.M. Lovelock High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions Int J Radiat Oncol Biol Phys 71 2008 484 490
28. G. Bertolini, L. Roz, and P. Perego Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment Proc Natl Acad Sci U S A 106 2009 16281 16286
29. M. Garcia-Barros, F. Paris, and C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159
30. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
31. J.A. Forquer, A.J. Fakiris, and R.D. Timmerman Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: Dose-limiting toxicity in apical tumor sites Radiother Oncol 93 2009 408 413
32. N. Pettersson, J. Nyman, and K.A. Johansson Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis Radiother Oncol 91 2009 360 368
33. N.E. Dunlap, J. Cai, and G.B. Biedermann Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 76 2009 796 801
34. B.S. Hoppe, B. Laser, and A.V. Kowalski Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: Who's at risk? Int J Radiat Oncol Biol Phys 72 2008 1283 1286
35. J.F. Fowler, P.W. Sheldon, and J. Denekamp Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons Int J Radiat Oncol Biol Phys 1 1976 579 592
36. J.M. Brown Clinical trials of radiosensitizers: What should we expect? Int J Radiat Oncol Biol Phys 10 1984 425 429
37. F.E. Halberg, D. Cosmatis, and L.L. Gunderson RTOG #89-06: A phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies Int J Radiat Oncol Biol Phys 28 1994 201 206
38. C.C. Ling, H.B. Michaels, and E.R. Epp Interaction of misonidazole and oxygen in the radiosensitization of mammalian cells Int J Radiat Oncol Biol Phys 6 1980 583 589
39. H.B. Stone Misonidazole in fractionated radiotherapy of a murine mammary carcinoma: Comparison of tumor and normal tissue response Int J Radiat Oncol Biol Phys 14 1988 957 962
40. J. Overgaard, and M.R. Horsman Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers Semin Radiat Oncol 6 1996 10 21
41. R.E. Drzymala, T.H. Wasserman, and M. Won A phase I-B trial of the radiosensitizer: Etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG study 95-02) Radiother Oncol 87 2008 89 92
42. K. Karasawa, M. Sunamura, and A. Okamoto Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-controlled randomised study Radiother Oncol 87 2008 326 330
43. R. Urtasun, P. Band, and J.D. Chapman Radiation and high-dose metronidazole in supratentorial glioblastomas N Engl J Med 294 1976 1364 1367
44. R. Urtasun, M.L. Feldstein, and J. Partington Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial Br J Cancer 46 1982 101 108